Respiratory syncytial virus: Early immunoprophylaxis in NICU preterm infants using palivizumab

被引：0
|
作者：
Bonaparte, J
Wu, SY
Pyati, S
机构：
[1] Cook Cty Childrens Hosp, Dept Pediat, Div Neonatol, Chicago, IL USA
[2] Finch Univ Hlth Sci, Chicago, IL USA
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1775
引用
收藏
页码：311A / 311A
页数：1
相关论文
共 50 条
  • [1] Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar
    Abushahin, Ahmad
    Janahi, Ibrahim
    Tuffaha, Amjad
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2018, 11 : 41 - 46
  • [2] Respiratory syncytial virus: Early palivizumab prophylaxis in the NICU
    Bonaparte, J
    Wu, SY
    Pyati, S
    Wilks, A
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 270A - 270A
  • [3] Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia
    Gabriel Pineros, Juan
    De la Hoz-Valle, Jose
    Galvis, Clara
    Celis, Astrid
    Ovalle, Oscar
    Cecilia Sandoval, Carmen
    Orrego, Jaime
    Vides, Saby
    Rojas, Iader
    Bustamante, Hernando
    Gallon, Carlos
    Alberto Mesa, Jaime
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (11): : 1708 - 1713
  • [4] Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab
    Lavoie, Pascal M.
    Solimano, Alfonso
    Taylor, Richard
    Kwan, Eddie
    Claydon, Jennifer
    Turvey, Stuart E.
    Marr, Nico
    [J]. JAMA PEDIATRICS, 2016, 170 (02) : 174 - 176
  • [5] Is immunoprophylaxis with palivizumab justified for respiratory syncytial virus?
    Paul, Siba P.
    Ball, Georgina M.
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (08) : 476 - 476
  • [6] Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals
    Colmenares, Alejandro
    Galvis, Clara
    Cabrales, Lina
    Ibata, Linda
    Marulanda, Juliana
    Ovalle, Oscar
    Puello, Dionisio
    Rojas, Catherine
    Africano, Martha
    Ballesteros, Adriana
    Posso, Hector
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals
    Galvis, Clara
    Colmenares, Alejandro
    Cabrales, Lina
    Ibata, Linda
    Marulanda, Juliana
    Ovalle, Oscar
    Puello, Dionisio
    Rojas, Catherine
    Africano, Martha
    Ballesteros, Adriana
    Posso, Hector
    [J]. PEDIATRIC PULMONOLOGY, 2022, 57 (10) : 2420 - 2427
  • [8] Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
    Shahabi A.
    Peneva D.
    Incerti D.
    McLaurin K.
    Stevens W.
    [J]. PharmacoEconomics - Open, 2018, 2 (1) : 53 - 61
  • [9] Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion
    Meissner, HC
    Welliver, RC
    Chartrand, SA
    Law, BJ
    Weisman, LE
    Dorkin, HL
    Rodriguez, WJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (03) : 223 - 231
  • [10] Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab
    Manzoni, Paolo
    Baraldi, Eugenio
    Luna, Manuel Sanchez
    Tzialla, Chryssoula
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2022, 39 : S7 - S13
12345